Patents by Inventor Capucine Trollet

Capucine Trollet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220273637
    Abstract: The invention relates to novel compounds which are inhibitors of the ribosome protein chaperone activity (“protein folding activity of the ribosome” or “PFAR”). More particularly, the invention relates to their use as PFAR-inhibitors, to compositions comprising them and to methods for treating proteinopathies.
    Type: Application
    Filed: July 9, 2020
    Publication date: September 1, 2022
    Inventors: MARTINE SIMONELIG, FRÉDÉRIC BIHEL, CÉCILE VOISSET, CAPUCINE TROLLET
  • Patent number: 11234994
    Abstract: The present disclosure relates to RNA interference (RNAi) reagents for treatment of oculopharyngeal muscular dystrophy (OPMD), compositions comprising same, and use thereof to treat individuals suffering from OPMD or which are predisposed thereto.
    Type: Grant
    Filed: April 13, 2017
    Date of Patent: February 1, 2022
    Assignee: Benitec Biopharma Limited
    Inventors: David Suhy, Michael Graham, Capucine Trollet, Alberto Malerba, John George Dickson
  • Publication number: 20200138849
    Abstract: The present disclosure relates to RNA interference (RNAi) reagents for treatment of oculopharyngeal muscular dystrophy (OPMD), compositions comprising same, and use thereof to treat individuals suffering from OPMD or which are predisposed thereto.
    Type: Application
    Filed: April 13, 2017
    Publication date: May 7, 2020
    Inventors: David SUHY, Michael GRAHAM, Capucine TROLLET, Alberto MALERBA, George J. Dickson
  • Publication number: 20100129371
    Abstract: The invention concerns a method for obtaining an antiserum directed against a proteinic toxin by administering to an animal a solution comprising a genetic construct encoding a toxin immunogenic fragment, then applying an electric field in the administering zone, and isolating the serum. The invention also concerns the antiserum obtainable by the method as well as the use of the solution for making a medicine for preventing or treating a toxic effect related to absorption by a mammal of a toxin. The invention is characterized in that said medicine is formulated to be administered by electrotransfer.
    Type: Application
    Filed: July 28, 2006
    Publication date: May 27, 2010
    Applicants: Centre National de la Recherche Scientifique (CNRS), Institute Pasteur, Institute National de la Sante et de la Recherche Medicale (INSERM), Universite Rene Descartes
    Inventors: Daniel Scherman, Pascal Bigey, Capucine Trollet, Michel R. Popoff, Yannick Pereira